Comprehensive identification of Salmonella enterica serovar typhimurium genes required for infection of BALB/c mice. by Chaudhuri, Roy R. et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Comprehensive identification of Salmonella enterica serovar
typhimurium genes required for infection of BALB/c mice.
Citation for published version:
Chaudhuri, RR, Peters, SE, Pleasance, SJ, Northen, H, Willers, C, Paterson, G, Cone, DB, Allen, AG,
Owen, PG, Shalom, G, Stekel, DJ, Charles, IG & Maskell, DJ 2009, 'Comprehensive identification of
Salmonella enterica serovar typhimurium genes required for infection of BALB/c mice.', Plos pathogens.
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
Plos pathogens
Publisher Rights Statement:
Copyright:  © 2009 Chaudhuri et al. This is an open-access article distributed under the terms of the Creative
Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium,
provided the original author and source are credited.
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 12. Sep. 2019
Comprehensive Identification of Salmonella enterica
Serovar Typhimurium Genes Required for Infection of
BALB/c Mice
Roy R. Chaudhuri1., Sarah E. Peters1., Stephen J. Pleasance1, Helen Northen1, Chrissie Willers1, Gavin K.
Paterson1, Danielle B. Cone1¤a, Andrew G. Allen2¤b, Paul J. Owen2¤c, Gil Shalom2¤d, Dov J. Stekel3, Ian G.
Charles4", Duncan J. Maskell1"*
1Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom, 2Arrow Therapeutics Ltd., London, United Kingdom, 3Centre for Systems
Biology, School of Biosciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom, 4Department of Molecular Biology and Biotechnology, University of
Sheffield, Sheffield, United Kingdom
Abstract
Genes required for infection of mice by Salmonella Typhimurium can be identified by the interrogation of random
transposon mutant libraries for mutants that cannot survive in vivo. Inactivation of such genes produces attenuated S.
Typhimurium strains that have potential for use as live attenuated vaccines. A quantitative screen, Transposon Mediated
Differential Hybridisation (TMDH), has been developed that identifies those members of a large library of transposon
mutants that are attenuated. TMDH employs custom transposons with outward-facing T7 and SP6 promoters.
Fluorescently-labelled transcripts from the promoters are hybridised to whole-genome tiling microarrays, to allow the
position of the transposon insertions to be determined. Comparison of microarray data from the mutant library grown in
vitro (input) with equivalent data produced after passage of the library through mice (output) enables an attenuation score
to be determined for each transposon mutant. These scores are significantly correlated with bacterial counts obtained
during infection of mice using mutants with individual defined deletions of the same genes. Defined deletion mutants of
several novel targets identified in the TMDH screen are effective live vaccines.
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Introduction
Salmonella enterica serovar Typhimurium (S. Typhimurium)
infection of mice is well established as a model of systemic typhoid
fever in humans [1]. The system is particularly useful for identifying
the genetic determinants of Salmonella virulence, usually by
comparing the in vivo growth of mutants with their wild type
parents. If a mutant is unable to survive in the mouse model it is
inferred that the disrupted gene is important for infection. Several
such mutants have been used to induce an immune response that is
protective against subsequent infection with wild type S. Typhimur-
ium, and have subsequently been translated for use as live
attenuated vaccines in humans and food-producing animals [2].
Most often, the mouse model has been used to investigate
Salmonella infection on a gene-by-gene basis. However, recent
developments in molecular biology allow pools of many mutants to
be screened in parallel. The first example of this was signature-
tagged mutagenesis (STM), which employs transposons containing
unique sequence tags that can be amplified by PCR and identified
by Southern hybridisation. These transposons are used to generate
mixed pools of mutants, which are used to infect an animal.
Bacterial DNA recovered from the animal can be interrogated for
the presence of the tags, and compared to similar data obtained
from the inoculum to identify attenuated mutants that do not
survive in vivo. This method was developed in a study of S.
Typhimurium in the mouse model of typhoid fever [3], using input
pools of 96 tagged mutants per animal. This led to the discovery of
Salmonella pathogenicity island 2 (SPI-2), which encodes a type III
secretion system (T3SS) that is critical for systemic infection and
intracellular pathogenesis [4]. The island was so named to
distinguish it from the well-characterised SPI-1, which also
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encodes a T3SS that is important in intestinal adhesion and
invasion [5]. Morgan et al. [6] used STM to identify S.
Typhimurium genes required for colonisation of calves and chicks,
using the same STM mutant library to infect the different hosts,
hence enabling comparison of the gene sets required for infection
of different livestock species. This study showed that SPI-1 and
SPI-2 mutants that were defective in colonization of calves were
able to colonize chicks and led to further characterisation of a SPI-
4 locus, required for infection of calves, but which appeared to be
less important in the intestinal colonization of pigs in a further
STM screen with this library [7].
There are various limitations associated with STM, including
the size of mutant pools given the number of unique tag sequences
that it is practical to use, and the fact that STM may not lead to
the identification of mutations that cause only a small reduction in
fitness to survive within a host [8]. An alternative approach
employs DNA microarray technology to screen a library of
transposon mutants. The parallel nature of microarrays allows the
simultaneous screening of much larger pools of mutants than is
possible using STM. The use of a custom transposon containing
an outward facing promoter allows the in vitro production of
labelled transcripts that are homologous to the regions flanking the
sites of transposon insertion. These can be used to hybridise to the
microarray, bypassing the need for a PCR amplification step that
can lead to non-reproducible results [9].
Microarray-based screening approaches have recently been
applied to the study of S. Typhimurium infection of mice. Using
such methods, Chan et al. [10] identified S. Typhimurium mutants
that cannot survive in RAW 264.7 macrophage-like cells. Within
the population of negatively selected mutants there was a
significant overrepresentation of genes located in SPI-1 (36/395)
and SPI-2 (51/395) indicating their importance in this infection
model. Screening the same transposon library through BALB/cJ
mice similarly revealed significant overrepresentation in the
negatively selected population of SPI-2 (27/187) and genes
involved in lipopolysaccharide (LPS) biosynthesis (9/187), with
an overrepresentation of SPI-1 genes (5/187) that fell marginally
short of significance at the 5% level. In a follow-up study, Lawley et
al. [11] used similar methods to study genes required by S.
Typhimurium to survive for up to 28 days in the spleens and livers
of Nramp1r mice, a model of the carrier state in human typhoid
fever. In this model genes from SPI-1 to SPI-6 were important for
systemic infection. The involvement of SPI-1 was a novel finding
since that island had previously been thought to be involved only
in the gastrointestinal phase of infection. It is possible that SPI-1
genes may be required for S. Typhimurium to re-establish
intracellular growth during persistent infection. Other genes
important for long-term systemic infection included LPS genes,
fimbrial genes, and horizontally acquired genes on the virulence
plasmid and within prophage elements.
Here we describe transposon mediated differential hybridisation
(TMDH) [12], and its application for the simultaneous, genome-
wide identification of genes required for growth of S. Typhimur-
ium in an acute infection of BALB/c mice over 2 days. Our
method improves significantly on earlier studies through the use of
high-density tiling microarrays and a novel bioinformatics
algorithm to determine the positions of transposon insertions with
a high degree of accuracy. This has allowed the unambiguous
identification of transposon mutants within 2824 S. Typhimurium
genes. Many of these are attenuated in the mouse typhoid model,
and may encode potential targets for the development of novel
antimicrobial therapeutics. We also show that defined deletion
mutants of some of the targets identified in the TMDH screen can
act as novel live-attenuated vaccines that protect against
subsequent challenge with wild-type S. Typhimurium. The
technology we present here is generic and can be applied to any
pathogen for which there is a genome sequence, a method of
generating large numbers of insertion mutants (in this case,
transposition) and a model of infection in which to identify
mutants that are attenuated for virulence.
Materials and Methods
Transposon-Mediated Differential Hybridisation (TMDH)
The TMDH procedure is outlined in Figure 1. A library of
around 10,000 transposon mutants was generated using custom
Tn5 and Mu transposons, containing outward-facing T7 and SP6
promoters. Genomic DNA was isolated from the library, and in
vitro transcription was induced from the T7 and SP6 promoters in
the presence of fluorescently-labelled dNTPs. DNaseI was used to
remove the genomic DNA, leaving labelled RNA run-offs, which
were hybridised to high-density tiling microarrays. Analysis of the
microarray data allows the genomic position of the transposon
insertions to be determined. This process was performed for the
original library (input), and for mutant pools recovered from the
livers of duplicate intravenously (i.v.) infected mice (output).
Mutants that are present in the input pool but which are absent or
less prevalent in the output pools are inferred to be attenuated in
vivo.
Construction of Tn5 and Mu TMDH transposons for use
in S. Typhimurium
TMDH transposons were based on Tn5 and Mu transposasome
constructs from Epicentre (EZ:Tn5 R6Kcori/KAN-2 Transposon
and HyperMu R6Kcori/KAN-1 Transposon). The constructs
were adapted for use in TMDH by the addition of outward-facing
T7 and SP6 promoters, which allow the generation of both left-
and right-arm RNA products corresponding to the regions
flanking the site of transposon integration in genomic DNA [13],
and incorporation of homing endonuclease recognition sites for I-
Sce-I and PI-Psp-I. These are rare-cutting enzymes and incorpo-
ration of their recognition sites into the transposons permits the
introduction of the sites into a bacterial genome following
transposition. Following digestion of transposed genomic DNA
with the rare-cutting enzyme, a ligation-capture method can be
carried out to rescue transposon ends and obtain flanking
Author Summary
Salmonella Typhimurium infection of mice is an estab-
lished model of systemic typhoid fever in humans.
Mutations that inactivate genes that are important for
virulence produce attenuated S. Typhimurium bacteria
that have potential for use as live vaccines. To investigate
the infection process we have produced a large pool of
random insertion mutants, and developed a novel micro-
array-based technology, Transposon Mediated Differential
Hybridisation (TMDH), that allows us to determine the
gene disrupted by each insertion. Comparison of data
obtained from the mutant pool grown in laboratory
culture (input) with equivalent data produced after
passage of the pool through mice (output) enables genes
that are important for the infection process to be
determined, since they are absent or less prevalent in
the output pool. We have constructed defined deletion
mutants of several of the candidate genes identified in the
TMDH screen, and have shown that they are attenuated
for virulence and effective live vaccines.
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sequence data (see below). The Tn5 and Mu TMDH transposons
were cloned into pBAD-TOPO (Invitrogen Life Technologies)
and transformed into TOP10 E. coli chemically competent cells
according to the Invitrogen protocol, with selection on LB agar
(Sigma-Aldrich) plates supplemented with 30 mg/ml kanamycin
(Sigma-Aldrich). Colonies were picked and grown in L-Broth
(Sigma-Aldrich) and plasmids were isolated using a Qiagen
QIAprep spin miniprep kit. The Tn5 and Mu constructs were
sequenced and have been deposited into the EMBL database
(accession numbers AX828670 and FN394965). The plasmids
were transformed into electrocompetent S. Typhimurium SL1344
with selection on 30 mg/ml kanamycin. Single colonies were
picked and grown up further in order to purify the plasmids using
a Qiagen QIAfilter Mega Plasmid Prep, which produced 2 mg of
plasmid in 2 ml of TE (pH 8.5).
Construction and characterization of transposon libraries
in S. Typhimurium SL1344
Tn5 and Mu TMDH libraries of around 5,000 mutants each
were generated in S. Typhimurium SL1344. 100 mg of Tn5 or Mu
pBAD-TOPO TMDH constructs were digested overnight at 37uC
with XmnI and NcoI (New England Biolabs) in NEB buffer 2 and
BSA in a final volume of 200 ml. The entire digest was then run
out on a 0.8% agarose gel, the insert bands were cut out and the
DNA was extracted from the gel using the Qiagen QIAquick Gel
Extraction kit and eluted in 50 ml TE (pH 8.5). The purified Tn5
and Mu transposon DNA was used in the Epicentre in vivo
transposition protocol using EZ-Tn5 Transposase or HyperMuTM
MuA Transposase as appropriate. Transposon DNA was added to
transposase and glycerol in a 1:2:1 ratio and incubated at room
temperature for 1 h. The transposasome complex was then
electroporated into electrocompetent SL1344 cells using a 2 mm
cuvette, at 200 V, 25 mF and 12 kV/cm. Recovery was in 1 ml
SOC medium (Gibco) at 37uC for 1 h then the bacteria were
plated out on Tryptic Soy Agar (TSA, Oxoid), supplemented with
50 mg/ml kanamycin, and grown overnight at 37uC. Colonies
were picked and grown overnight at 37uC in 0.5 ml L-Broth
supplemented with 25 mg/ml kanamycin, in 2 ml 96-well blocks
(Fisher Scientific). Overnight cultures of 5,184 Tn5 and 5,184 Mu
TMDH transposon mutants were stored at 280uC in 20%
glycerol in L-Broth in 96-well microtitre plates.
96 of the Tn5 mutants were streaked on LB agar plates
supplemented with 100 mg/ml ampicillin to check for sensitivity.
All were sensitive, showing that there had been no carry-through
of undigested pBAD-TOPO construct into the gel-purified
transposon DNA. Tn5 mutants 1 to 50 were screened on
microscope slides for agglutination with anti-O4 antiserum (Remel
Europe Ltd.). All mutants agglutinated with the antiserum
indicating the bacteria expressed an intact O-antigen following
electroporation.
The in vivo TMDH procedure: mouse model of infection
To prepare inocula for in vivo TMDH in mice, 5,184 Tn5 and
5,184 Mu TMDH transposon mutants were grown up individu-
ally in 1 ml L-Broth in 2 ml 96-well blocks, at 37uC overnight.
Cultures were combined into 20 pools of 480 mutants and 2 pools
of 384 mutants for inoculation into mice. 3 ml of each pooled
culture was removed for measurement of OD600 in order to
estimate bacterial numbers. The remainder was used for
preparation of input-pool genomic DNA (see below). Cells from
3 ml cultures were recovered by centrifugation (43006g for
10 min), resuspended in 3 ml phosphate buffered saline, pH 7.5
(PBS) and diluted to give an appropriate number of bacteria for
the inoculum. An aliquot of the inoculum was plated on LB agar
in triplicate in order to obtain an accurate viable count. A dose of
106 colony-forming units (CFU) was chosen empirically as
sufficient to prevent random dropout of mutants, and was
inoculated in 0.2 ml PBS into the tail veins of duplicate six- to
eight-week-old BALB/c mice (Harlan). All animal procedures
were carried out in accordance with the Animals (Scientific
Procedures) Act (1986).
Recovery of organs from infected mice
Spleens and livers were recovered 2 days post-infection and
homogenised in 10 ml distilled water, then 100 ml aliquots were
plated for viable counts on LB agar. The remainder of the
homogenate was plated on three 50 ml LB agar plates and
incubated at 37uC overnight.
Preparation of genomic DNA
For each pool of mutants, genomic DNA from the input pool
and the two liver output pools was prepared. For the input pools,
bacteria were collected from 200 ml of pooled overnight culture
by centrifugation in a benchtop centrifuge at 43006g at 15uC for
10 min. For the output pools, bacteria from confluent plates were
harvested by adding 10 ml of L-Broth to each plate, then
bacterial suspensions were pooled and vortexed, and cells from a
20 ml aliquot were recovered by centrifugation at 43006g for
10 min. In each case, the pellet was resuspended in 20 ml of Tris
(10 mM, pH 8) EDTA (10 mM) (TE), then 400 ml of 10 mg/ml
lysozyme (Sigma-Aldrich) in water was added and incubated at
42uC for 30 min. 200 ml of Qiagen Proteinase K, 40 ml of Qiagen
RNaseA, and 2 ml of 10% (w/v) N-lauryl sarcosine (Sigma-
Aldrich) were added and incubated for 1 hr (input pools) or 2 hr
Figure 1. Diagrammatic representation of the TMDH process.
(A) A library of transposon mutants is obtained using a custom
transposon with outward-facing T7 and SP6 promoters. Genomic DNA
is extracted from the library and digested using a restriction
endonuclease (RsaI). Labelled RNA run-offs are obtained from the T7
and SP6 promoters by in vitro transcription. (B) The labelled RNA run-
offs are hybridised to genome-wide tiling microarrays. By examining the
distribution of microarray signals between RsaI restriction sites (vertical
black lines) it is possible to infer the location of the transposon (green
triangle). Comparison of the library grown in vitro (input) with the
library obtained after passage through a mouse (output) allows
attenuating mutants to be identified, since they give lower signals in
the output.
doi:10.1371/journal.ppat.1000529.g001
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(output pools), or until completely lysed (clear) at 50–55uC.
Lysates were extracted by adding 1 volume of buffered phenol
(Sigma-Aldrich), shaking, and centrifuging at 70006g for 10 min.
The aqueous layer was removed and extracted with 1 volume of
phenol:chloroform:isoamyl alcohol (IAA) (25:24:1), then once
more with chloroform:IAA (24:1). DNA was precipitated with 2
volumes of ethanol, recovered, washed in 70% (v/v) ethanol, then
transferred to a 1.5 ml tube containing 0.5 ml of TE and left at
4uC to dissolve. The DNA concentration and A260/A280 ratio
were measured on a NanoDrop 1000 spectrophotometer
(Thermo Scientific). Genomic DNA was also prepared similarly
from a 50 ml wild-type S. Typhimurium SL1344 culture grown
overnight at 37uC in L-Broth for use as an untransposed control
(see below).
Restriction digests and in vitro transcription
10 mg of genomic DNA from each TMDH input and output
pool, and from the untransposed control DNA, was digested using
RsaI (Promega) overnight at 37uC. Digested DNA was cleaned
using a Qiagen QIAquick PCR Purification Kit and eluted in
30 ml RNase-free water (Qiagen). The DNA concentration and
A260/A280 ratio were measured on a NanoDrop 1000 spectro-
photometer. Equal amounts of digested DNA from 2 or 3 pools of
mutants were combined to give 8 sets of 960–1440 mutants each
for microarray analysis (see Table 1). In vitro transcription (IVT)
was induced from the transposon T7 and SP6 promoters using
500 ng of genomic DNA in a 20 ml MEGAscript T7 Kit or
MEGAscript SP6 Kit reaction (Ambion Inc.), with half the UTP
replaced with 5-(3-aminoallyl)-UTP (aa-UTP; Ambion Inc.). RNA
run-offs were treated with TURBO DNase (Ambion) and purified
on Qiagen RNeasy MinElute columns. Purified RNA from input
or output pools was post-labelled with Cy5 and RNA from wild-
type (untransposed) control DNA with Cy3, using CyDye Post-
Labelling Reactive Dye Packs (GE Healthcare), and the reactions
were stopped with 4 M hydroxylamine (Sigma-Aldrich). The
resultant labelled RNA was purified again on Qiagen RNeasy
MinElute columns, and used for hybridization to DNA micro-
arrays.
Microarray methods
A set of 60-mer oligonucleotide probes was designed based on
the S. Typhimurium LT2 genome sequence (accession numbers
AE006468 and AE006471). The probes were spaced approxi-
mately every 100 bases on both strands across the whole genome,
with the exception of repetitive regions for which unique probes
could not be designed. As a different S. Typhimurium strain,
SL1344, was used for the TMDH experiment it was necessary to
identify the positions of the SL1344 genome that corresponded to
each probe. The SL1344 genome sequence and preliminary
annotation was obtained from the Wellcome Trust Sanger
Institute (http://www.sanger.ac.uk/Projects/Salmonella). Each
microarray probe sequence was used as the query in a blastn
search of the SL1344 genome sequence, and was considered to
match uniquely if the top hit showed .80% identity over .50%
of the length of the probe, and the second hit did not fulfil both
those criteria. Uniquely matching probes were used in the TMDH
analysis, with their hybridization position on the SL1344 genome
determined from the BLAST result. Any probes that contained an
RsaI restriction site within the central 30 bases were omitted from
the analysis, since the probe signal could reflect transcript from
either side of the restriction site.
Custom microarrays with 26105K features per slide were
obtained from Agilent Technologies. Each Cy5-labelled RNA run-
off from an input or output pool was combined with an aliquot of
Cy3-labelled control RNA generated from the same promoter,
and fragmented at 60uC for 30 minutes using Agilent Fragmen-
tation Reagent. Fragmented RNA was then hybridised to
microarrays in Agilent Gene Expression HI-RPM hybridisation
buffer at 65uC for 17 hours in Agilent hybridisation chambers and
backings in an Agilent hybridisation oven. Following hybridisa-
tion, the arrays were washed with Agilent wash buffers 1 and 2
according to the manufacturer’s instructions, followed by one wash
in acetonitrile (Sigma-Aldrich) and drying in Agilent Stabilisation
and Drying Solution. The arrays were scanned using an Agilent
G2565BA scanner using an extended dynamic range of 10% and
100% PMT, and the images analyzed using the Agilent Feature
Extractor software version 9.3.5.1. The raw microarray data were
uploaded to ArrayExpress (accession number E-MEXP-2076).
Experimental design and microarray analysis
A separate microarray experiment was performed for each set of
960–1440 mutants. Each experiment consisted of six microarrays,
one each for the T7 and SP6 RNA run-offs from the input pool
and from the two biological replicate output pools. The IVT
product from each mutant pool was labelled with Cy5 and
hybridised to the microarray together with the Cy3 labelled IVT
product from an untransposed control strain. The untransposed
control has two purposes: it allows normalisation of the T7 and
SP6 signals without any problems associated with dye bias, and
acts as a control to allow identification of the sites of transposon
insertion in the input pool.
Microarray data were imported into R [14] using the
Bioconductor package Limma [15]. The raw signals were
normalised to account for sequence-dependent variation using
the Naef and Magnasco method [16,17], implemented in R by
Royce et al. [18]. Briefly, this procedure uses a linear model to
predict the contribution to the probe signal intensity of each
possible nucleotide at each position in the probe sequence. A
predicted log signal intensity is computed for each probe based on
the model, and subtracted from the observed log signal intensity.
Since the transcripts from each transposon promoter are likely
to influence the signal from multiple probes, the individual probe
signals cannot be treated as statistically independent. To
circumvent this problem the data from all the probes within a
single RsaI restriction fragment were summarised to give a single
data point. This procedure is illustrated in Figure 2. A single
transposon insertion within a restriction fragment is expected to
produce transcripts that will hybridise to probes 59 from the
transposon on both strands (‘‘on’’ probes). All other probes in the
Table 1. Number of mutants investigated in each array set.
Array Set Number of Mutants
Set1 960 (26480)
Set2 960 (26480)
Set3 1440 (36480)
Set4 1440 (36480)
Set5 1440 (36480)
Set6 1440 (36480)
Set7 1440 (36480)
Set8 1248 (16480, 26384)
In parentheses are the number and size of the mutant pools used to infect
individual mice. These were pooled as indicated for the microarray experiments.
doi:10.1371/journal.ppat.1000529.t001
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restriction fragment should produce only a background signal (‘‘off
probes’’). The most likely position of a transposon is therefore
determined as the position where the sum of the signals from the
‘‘on’’ probes minus the sum of the ‘‘off’’ probe signals is maximal,
and the summary score is calculated based on the ‘‘on’’ probe
signals. For large restriction fragments it is not appropriate to use
an average of all these signals as a summary score, since signal
intensities tend to decrease for probes that are distant from the
transposon. A sliding window approach was used, with the
geometric mean of the signals calculated for each window of three
consecutive probes. The highest value was used as the summary
score for that restriction fragment.
The situation is complicated somewhat if more than one
transposon is present within a single restriction fragment within
the same array set. It is possible to distinguish between two inserts
within the same fragment if they are in opposite orientations, since
the transcripts that correspond to the same strand will be derived
from different promoters and hence will be detected on different
arrays and not interfere with each other. For this reason each
restriction fragment is assigned two summary scores, one for each
possible transposon orientation. If multiple transposons are present
in the same orientation then the signals will interfere, and it may
be impossible to determine the location of each insert. However,
since no more than 1440 mutants were investigated on the same
array, this is unlikely to represent a significant problem for the
analysis of our data.
To determine the position of the transposon insertions present
in the input pool of each set of mutants, summary scores were
calculated for the Cy5 signals from the Input T7 and SP6 arrays,
and separately for the Cy3 (control) signals from the same arrays.
The summary scores are analogous to data derived from a
traditional expression microarray, and can be analysed in a similar
manner. To do this, the input and control summary scores were
converted to the red and green signals of a Limma RGList object
[15]. The signals were normalised using a loess curve, and
displayed on a plot of log2 signal intensity ratio (M) against log2
average signal intensity (A; see Figure 3). An M cut-off value of 2
was used to identify summary scores likely to correspond to
transposon insertions.
To compare the input and output pools, a similar procedure was
followed. In this case the untransposed control signals were used as a
standard reference to normalise between arrays, and the ratio of
sample:reference signal for each probe was used to calculate the
summary scores. This was done separately for the input and two
output pools, and the resulting scores analysed in the same manner
as single-colour Affymetrix data in Limma [15]. The scores were
normalised using a loess curve, as implemented in the Bioconductor
package affy [19], and log2 fold change (logFC) and P-values were
calculated using the linear models implemented in Limma, applying
the method of Benjamini and Hochberg [20] to account for multiple
testing. These logFC values were normalised between array sets by
dividing by the median absolute deviation. The normalised logFC
scores and P-values from each set were combined and used to assess
the in vivo survival of each of the mutants previously identified within
the input pool (see Table S1).
Experimental verification of transposon insertion
locations
As part of the TMDH development process, 50 Tn5 mutant
colonies were selected from Set6 for DNA sequencing-based
verification of the position of the transposon insertion using a
ligation capture procedure. The mutants were grown up
individually in 2 ml TSB (Oxoid) in the presence of 50 mg/ml
kanamycin overnight at 37uC and 200 rpm. 1.5 ml of each was
used to prepare chromosomal DNA using the Qiagen DNeasy
tissue kit. 5 ml of each of the fifty chromosomal preps was digested
with EcoRV (NEB) in a final volume of 20 ml, overnight at 37uC.
The EcoRV was heat inactivated at 80uC for 20 minutes. The
20 ml digest was then re-ligated in 100 ml final volume using Gibco
T4 DNA ligase for 48 hours at 4uC. Each re-ligation was then
individually cleaned up using a Qiagen gel extraction spin column
and eluted in 50 ml water. 4 ml of cleaned up, re-ligated, EcoRV-
digested chromosomal DNA from each mutant was electroporated
into 40 ml of electrocompetent pir+ cells using a 1 mm cuvette,
100 V, 25 mF and 20 kV/cm, outgrowth was in 1 ml SOC
Figure 2. Diagrammatic representation of the TMDH scoring
system. The most likely position of the transposon is inferred from the
microarray data, and the probes that would detect the signals from a
transposon in that position are identified. To summarize the signals of
these probes into a single data point, a sliding window approach is
used. The geometric mean of the signals is determined for each
consecutive set of 3 probes. The highest such value is used to represent
the signal for that restriction fragment.
doi:10.1371/journal.ppat.1000529.g002
Figure 3. Sample MA plot comparing microarray signals
derived from transposed and untransposed DNA. Plot shows
log2 signal intensity ratio (M) against log2 average signal intensity (A)
for the summary scores derived from RNA run-offs obtained from
transposed and untransposed DNA. An M value of 2 was used as the
cut-off to infer the presence of a transposon within a restriction
fragment.
doi:10.1371/journal.ppat.1000529.g003
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medium (Gibco) at 37uC for 1 h, each of the 50 transformations
was then recovered by centrifugation and the pellet resuspended in
50 ml L-Broth and plated out on LB agar supplemented with
30 mg/ml kanamycin, and incubated overnight at 37uC. From
each plate where colonies grew, one colony was picked and grown
up in 5 ml L-Broth plus 30 mg/ml kanamycin at 37uC overnight.
46 Qiagen minipreps were carried out and 10 ml plasmid DNA
was sequenced according to the Beckman CEQ protocol using a
transposon-specific primer. Salmonella sequence data was obtained
for 37 of the mutants.
Additionally, 13 transposon mutants (see Table S2) were
selected from Set1 and Set3 based on the results of the microarray
analysis. For each mutant, the region flanking the transposon was
amplified by PCR, using a transposon-specific primer and a gene-
specific primer. The gene-specific primer was designed to anneal
,200 bp from the approximate position of the transposon as
predicted during the automated microarray analysis. PCR was
performed using the Expand High Fidelity PCR System (Roche)
on a Biometra T3000 thermocycler. Reactions contained 0.5 mM
dNTPs (Bioline), 1 mM each primer (Sigma-Genosys), 100 ng
template DNA, 16 Expand PCR buffer and 0.75 ml of Expand
polymerase mix in a total volume of 50 ml. Bands matching the
expected products were excised from a 0.8% agarose (Invitrogen)
gel, extracted with a QIAquick Gel Extraction kit (Qiagen),
purified further with a QIAquick PCR Purification kit (Qiagen),
and then sequenced directly using the transposon-specific primer
by the Department of Biochemistry DNA Sequencing Facility at
the University of Cambridge.
The sequence data were examined using FinchTV v 1.4.0
(Geospiza), then used as queries in blastn searches against a
database containing the SL1344 genome, together with the
sequences of the Mu and Tn5 transposons. For each mutant,
the transposon could be identified as Mu or Tn5 based on which
of those sequences gave a higher scoring BLAST hit. The position
of the highest-scoring alignment with the SL1344 genome allowed
the insertion location and orientation of the transposon to be
determined.
Investigation of attenuation in defined deletion mutant
strains
Defined deletion mutants of S. Typhimurium were constructed
by a modification of the ET-cloning procedure [21]. Genes to be
deleted were replaced with a kanamycin resistance cassette from
pUC4Kan (Amersham). PCR was used to amplify the antibiotic
resistance cassette with 59 and 39 60 bp homology arms
complementary to the flanking regions of the gene to be deleted.
PCR products were electroporated into S. Typhimurium LB5010
[22] containing the plasmid pBADlred expressing the phage
lambda genes exo, bet and gam under an inducible arabinose
promoter, having induced these cells with 0.2% (w/v, final
concentration) arabinose (Sigma-Aldrich) prior to making them
electrocompetent. Candidate mutant colonies were selected on LB
agar plates supplemented with 25 mg/ml kanamycin. Verification
of allelic replacement was carried out by a test PCR using primers
designed to regions 150 bp upstream and downstream of the gene
of interest. The PCR products were then TA-cloned into
pCRH2.1-TOPO (Invitrogen-Life Technologies) following the
manufacturer’s instructions, and the resultant plasmids were
sequenced to confirm the DNA sequence at the junction of the
antibiotic resistance cassette and the disrupted gene. The
mutations generated in S. Typhimurium LB5010 were transduced
using bacteriophage P22 [23] into strain SL1344 for in vivo
virulence studies [24]. Transductants were selected on LB agar
supplemented with 25 mg/ml kanamycin and were screened for
agglutination with anti-O4 serotype-specific antiserum (Remel
Europe Ltd.) in addition to verifying the presence of the mutation
by PCR and sequencing, as described above.
Six- to eight-week-old BALB/c mice (Harlan) were used for
infection studies using the individual defined deletion mutants.
Bacteria were inoculated into L-Broth, supplemented with 25 mg/
ml kanamycin if appropriate, and left to stand overnight at 37uC.
Bacteria were harvested and re-suspended in PBS and adjusted as
appropriate (usually 56103 CFU ml21 for i.v. infections) and the
viable count of the inoculum was confirmed by plating serial
dilutions on LB agar. Mice were inoculated with 0.2 ml of the
appropriate dilution of the bacterial suspension via the tail vein.
Three or four mice per group were killed by cervical dislocation at
each time-point post-infection. The spleens and livers of infected
mice were removed and placed in 10 ml sterile distilled water and
homogenised using a StomacherH 80 Lab System (Seward). Viable
mutants were quantified by plating various dilutions of homoge-
nised organs in LB agar.
For protection experiments, six- to eight-week old BALB/c mice
(Harlan) were immunised i.v. with 1.06105 CFU per mouse of the
defined deletion mutant, grown as above, and 4 months later
challenged i.v. with 104 CFU per mouse of the virulent parent
strain, SL1344. One day prior to the challenge two mice per group
were culled and spleens and livers were plated on LB agar to assess
the pre-challenge bacterial counts in the organs. When no bacteria
were present in these pre-challenge counts, the challenge
experiment was undertaken. Non-immunised, age-matched mice
were challenged with the same dose of virulent bacteria at the
same time as the immunised mice. Three to eight mice per group
were killed at each time-point post-challenge and organs plated for
viable counts of bacteria as above.
Results
Identification of transposon insertion sites using TMDH
A list of the transposon mutants identified from the microarray
data, together with normalised log2-fold change (attenuation)
scores and P-values is shown in Table S1. In the table and below,
all SL1344 genes are referred to using the name of their LT2
homologue. The list is also available as an online database at
http://www-tmdh.vet.cam.ac.uk. This database includes a facility
to inspect manually the normalised microarray data and its
relationship to the genome sequences of S. Typhimurium SL1344
and LT2 (see Figure 4). This provides a powerful tool to confirm
the position of transposons determined by the automated
algorithm.
A graphical representation of the distribution of attenuation
scores is shown in Figure 5. The majority of transposon insertions
do not affect virulence in this mouse model and show an
attenuation score not significantly different from 0. Of the
mutants that significantly differ between the input and output
pools, the majority are attenuated and under-represented in the
output, with an attenuation score of ,0. We infer that these
mutants have a transposon that disrupts a gene important for
infection. A few mutants are over-represented in the output pool
relative to the input, suggesting that they may have a mutation
that leads to an increase in competitiveness during the infection
process. The TMDH analysis procedure allows the positions of
transposons to be determined to within a region of around
200 bp. From a total of 10368 mutants, the position of the
transposon insertion could be identified using TMDH for 8533.
Of these, 6108 could be unambiguously mapped to 2824 different
S. Typhimurium genes.
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Verification of transposon insertion sites predicted by
TMDH
To support the accuracy of the algorithm used to predict
transposon insertion sites from the microarray data, sequence data
from the regions flanking 50 transposons were obtained (see
Methods). 13 of these were selected for sequencing as there was a
clear indication of the location of the transposon from the
microarray data. This set was chosen to include several mutants
that appeared to be attenuated in vivo. The other 37 mutants
chosen for sequencing were selected randomly from set 6. BLAST
searches against the SL1344 genome using the obtained sequence
data allowed the position and orientation of the transposon to be
accurately determined. The results of this analysis are shown in
Table S2. From the 50 transposons investigated, the positions of
46 were within the range predicted by the TMDH analysis. The
remaining 4 were situated in positions that did not allow their
detection using TMDH, due to the distribution of RsaI restrictions
sites and microarray probes (see Discussion).
Investigation of defined deletion mutants of targets
selected by TMDH
Defined deletion mutants were constructed in SL1344 for 47
different genes. These genes were selected to include a
representative range of attenuation scores. The in vivo growth of
Figure 4. Example of TMDH data displayed using the online database. The database is available at http://www-tmdh.vet.cam.ac.uk.
doi:10.1371/journal.ppat.1000529.g004
Figure 5. Curve showing the ordered attenuation scores for the
8533 mutants identified by TMDH. Error bars indicate 95%
confidence intervals. Red error bars indicate mutants that significantly
deviated from 0 (P,0.05), grey indicates genes that did not significantly
change in the output.
doi:10.1371/journal.ppat.1000529.g005
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each of these was assessed by i.v. infection of BALB/c mice, and
compared to infection with the parental SL1344 as a control (see
Table S3). Figure 6 shows a plot of the mean bacterial viable
counts in the mouse organs on day 3 post-infection, as a function
of the mean attenuation score for all the transposon mutants that
were unambiguously identified as being within that gene. This plot
shows a significant correlation (R2 = 0.54, P = 1.761029).
Immunisation with attenuated mutants identified by
TMDH and protection against challenge with the virulent
parent strain
SL1344 trxA and SL1344 atpA were chosen from the TMDH
screen as live-attenuated vaccine candidates. BALB/c mice were
immunised i.v. with 1.06105 CFU per mouse of SL1344 trxA or
SL1344 atpA. SL3261, an aroA mutant of SL1344 which is a well-
characterised live-attenuated vaccine strain [24], was used as a
control. After 4 months, these mice and age-matched, un-
immunised controls were challenged with an i.v. dose of 16104
CFU SL1344 per mouse. Figure 7 shows bacterial loads in spleens
and livers following this intravenous challenge with SL1344. The
bacterial counts are represented as the geometric means and
standard errors of one representative experiment from two with
similar results. Immunisation with SL1344 trxA and SL1344 atpA
resulted in protection of mice against i.v. challenge with the
virulent parent strain, as shown by the fact that the viable counts
in the organs of immunised animals were lower by several fold
than the viable counts in the control un-immunised animals.
Infections in un-immunised mice were only allowed to proceed to
day 4 before mice were too ill to survive and were culled. In
contrast, immunised mice were still well 14 days after challenge
with SL1344 showing that atpA and trxA mutants when delivered
intravenously can be used as live-attenuated vaccine strains to
protect against a subsequent intravenous challenge. We also
investigated the potential of a tolA mutant to protect against
virulent challenge. tolA was selected from the TMDH screen, and
encodes part of the Tol-Pal complex in the inner membrane of
Gram negative bacteria. SL1344 tolA was attenuated in mice via
the oral and i.v. routes and i.v. immunisation with SL1344 tolA
provided significant protection against subsequent challenge with
SL1344, delivered i.v or orally [25].
Discussion
Comparative in vivo TMDH
We have developed TMDH, a microarray-based screen that
exploits customised transposons with outward-facing promoters
[13] to allow identification of the disrupted genes in pools of
transposon mutants [12]. High-density tiling microarrays and a
novel bioinformatic algorithm are used to locate the site of
transposon insertion with high resolution. This technology is
Figure 6. Plot of mean colony counts for individual defined mutant infections against mean TMDH attenuation score. Colony counts
were obtained 3 days after infection with defined deletion mutants (103 CFU per mouse). Mean values were calculated for at least three mice per
mutant, and compared with the mean TMDH attenuation score for the same gene. The plot shows a significant correlation, demonstrating that TMDH
is an effective screen for identifying genes that are important for infection.
doi:10.1371/journal.ppat.1000529.g006
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generic with many potential applications. One possibility is the use
of large transposon pools to saturate potential sites of insertion,
and hence infer genes essential for survival and replication as those
which do not contain transposons [26].
An alternative application is comparative in vivo TMDH,
which exploits the TMDH method to compare a pool of mutants
harvested from an infection model with the same pool grown in
vitro, to identify mutants that are attenuated in vivo. Again this is a
generic technology and could be applied to the study of any
bacterial pathogen for which a genome sequence, a suitable
transposon and a reproducible model of infection are available.
In the work presented here we have used TMDH to investigate
genes important for S. Typhimurium SL1344 infection of BALB/
c mice.
Comparison of TMDH with earlier microarray-based
methods
There are several previous examples of the use of DNA
microarrays to investigate the distribution of transposon insertions
in bacteria. The majority of these employ large PCR-product
microarrays, with a small number of probes for each gene [9,10,27–
31]. The use of high density tiling microarrays offers a significant
improvement over these methods, allowing sub-genic resolution of
individual transposon insertion sites. An additional advantage of
tiling arrays derives from having probe coverage of the entire
genome. This removes the reliance on annotated genome features,
reduces the possibility that transposons will be in regions not
covered by the microarray, and allows intergenic regions that may
be of interest to be determined. One previous study has reported the
use of genome tiling microarrays to identify the position of
transposons within a bacterial genome [32]. However, the analysis
procedure used in that study was a straightforward examination of
the microarray signals using arbitrary signal-strength cut-offs and
manual inspection. This sort of analysis would not be suitable for
interrogation of large pools of mutants such as those screened in the
current work. Our analysis method is more sophisticated, allowing
an unbiased quantitative measure of the relative fitness of each
transposon mutant to be determined.
Prediction and verification of sites of transposon
insertion
In total, 10368 transposon mutants were obtained and
investigated using TMDH. From these, 8533 (82.3%) putative
insertion sites were identified during the automated microarray
analysis. The remainder includes transposons that could not be
located as they were inserted in regions of the SL1344 genome not
covered by the microarray (including repetitive regions and
plasmids or strain-specific islands not present in LT2). Other
undetected transposons include those that inserted within small
RsaI restriction fragments, and some that could not be unambig-
uously located due to the presence of two or more transposons in
the same orientation within the same restriction fragment. It
would be possible to increase the recovery rate by repeating the
TMDH procedure using additional restriction enzymes and
alternative microarray designs.
The locations of the transposon insertion sites were indepen-
dently verified by obtaining DNA sequence data from the
regions flanking the insert for 37 randomly selected mutants.
BLAST searches of the SL1344 genome using the sequence data
allowed the location and orientation of each of the transposons
to be unambiguously determined. 33 (89.1%) of these were in
positions within the range identified by the automated TMDH
analysis. The analysis of the remaining 4 insertion events
highlights some of the limitations inherent in the method: two
were incorrectly identified due to the presence of additional
transposons in the same orientation within the same restriction
fragment, one was not identified as the insertion was within a
small restriction fragment, and one gave a low signal that did
not exceed the threshold value used to filter false positives from
the dataset. Nevertheless, the correct location of a high
percentage of the transposons suggests that the technology is
suitable for use as a screening method.
Additional support was obtained by PCR amplification of the
regions flanking 13 transposons, using a transposon-specific primer
and one designed to be adjacent to the insertion position predicted
by the automated analysis. Again, sequence data were obtained
using a transposon-specific primer and the position of the
transposon relative to the SL1344 genome was determined using
Figure 7. Use of attenuated mutants identified by TMDH as live vaccines. Growth curves for intravenous challenge of mice with SL1344 (104
CFU per mouse), 4 months after intravenous immunisation with SL1344 trxA, SL1344 atpA or SL3261 (105 CFU per mouse). Bacterial load in (A) spleens
and (B) livers of immunised and age-matched un-immunised mice is shown as mean log10 CFU per organ. Error bars indicate standard error (n = 3–8).
doi:10.1371/journal.ppat.1000529.g007
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BLAST. For this set, all 13 transposons were located within the
range predicted by the automated analysis.
Identification of attenuated S. Typhimurium SL1344
mutants
The TMDH analysis procedure distils the microarray data into
a form equivalent to a standard expression microarray, and allows
the direct comparison of the input and output signals to give a
fold-change. This is expressed as a log2 value and referred to as an
‘‘attenuation score’’. Negative values indicate that the mutant is
attenuated, while positive values suggest that the mutant has a
competitive advantage in vivo. Use of replicate mice additionally
allows the estimation of a P-value. The data for all 8533 mutants
are available in Table S1, ordered by attenuation score.
Importantly, the top (most attenuated) end of the list includes
many genes that have well established roles in virulence. These
include numerous genes that encode structural components of the
SPI-2 T3SS or associated regulators, chaperones and secreted
effector proteins. The requirement of this system for S.
Typhimurium infection and persistence is well established [4],
and virtually all the transposon mutants within this region are
highly attenuated (see Figure 8). Interestingly, transposon
insertions within the other SPI regions present in S. Typhimurium
are not identified as strongly attenuating in our screen (see
Figure 9) – this is probably a consequence of the chosen mode of
infection (i.v.) and the use of the mouse as the model species.
Beside SPI-2, other well established virulence-related genes that
are identified in our dataset include: the aromatic amino acid
biosynthesis (or pre-chorismate) pathway genes aroA, aroC and
aroD, mutants of which are prototype live attenuated Salmonella
vaccines [24,33,34]; the purine biosynthesis genes purA, purD, purF,
purG, purH, guaA and guaB [3,35,36]; LPS core biosynthesis genes
[37]; O-antigen biosynthesis genes [38]; and the virulence plasmid
spv genes [39]. Presumably because of the requirement for the spv
operon, plasmid partitioning is required for virulence, and both
parA and parB mutants are attenuated. The latter is surprising since
parB was described as being dispensable for partitioning in pSLT
[40].
As might be expected, bacteria with mutations in many genes
previously associated with resistance to acid, high temperature and
oxidative stress are unable to survive in vivo. Some of these are
known to be involved in virulence, including slyA [41,42], htrA
(degP) and degS [21,43,44]. Other genes that have been associated
with stress responses but not previously demonstrated to be
attenuated in vivo include the tRNA base modification gene miaA
[45]. The fatty acid biosynthesis gene fabF (atrB) is associated with
the acid tolerance response in S. Typhimurium LT2, but previous
investigation of a mutant in the SL1344 background did not find
Figure 8. TMDH data obtained from array set 6 for SPI-2 and the surrounding regions. Genes are coloured according to their GC content
as indicated by the scale bar. The region of SPI-2 that encodes a type-III secretion system can be identified by its low GC content. The TMDH signals
within this region are abolished in the output datasets, indicating that transposon insertions in this region are attenuating. Insertions in the flanking
regions give comparable signals in the input and output datasets.
doi:10.1371/journal.ppat.1000529.g008
Salmonella Infection Genes
PLoS Pathogens | www.plospathogens.org 10 July 2009 | Volume 5 | Issue 7 | e1000529
any significant effect on acid tolerance or virulence [46]. In
contrast, our results suggest that transposon insertions within this
gene are attenuating. This may indicate that the fabF mutation
leads to a mild effect on virulence that is only evident in
competitive assays. DNA recombination and repair is also
important, with our data confirming the importance of dam [47],
recA [48] and recG [49] for virulence. Mutations in the genes recD,
and to a lesser extent recF, recJ and recQ also appear to be
attenuating from our data, however previous studies have not
found recD, recF and recJ mutants to be attenuated during
individual infection assays [50,51].
Other systems that are important for infection and persistence
in our model include carbon metabolism, with attenuating
mutants found in a number of genes involved in glycolysis (pgm,
ptsG, crr and tpiA), the TCA cycle (sucABC and sdhABC), mannose
utilisation (mtlA, mtlD, rfbM and manA) and oxidative phosphory-
lation (the nuo locus, atpABFI, cyoAB and cydA [52]). Zinc transport
(znuABC) [53] and phosphate transport (pstABCS) are also
important for virulence, as is pyrimidine metabolism (pyrBCDE,
and carAB). Mutants of two genes involved in the thioredoxin
system, trxA and trxB, are identified as attenuating by TMDH. Of
these trxA is known to be important for infection of mice [54]. trxB
mutants are not attenuated in individual infections [54] but do
show reduced intracellular proliferation, which may account for
their attenuation in the TMDH competitive infection screen.
Genes identified in our screen that had not previously been
associated with Salmonella virulence include components of the Tol-
Pal system that contributes to membrane stability (tolA and tolB)
[25]; yqiC, which encodes a putative cytoplasmic protein with no
functionally characterised homologues; the putative regulator
encoded by STM4030; ychK, which encodes a patatin-like lipolytic
enzyme; and ybjT, which encodes a putative nucleoside-diphos-
phate-sugar epimerase. Interestingly, the patatin-like ExoU is a
type III-secreted cytotoxin and virulence factor of Pseudomonas
aeruginosa [55], and the E. coli O157:H7 homologue of ybjT is
induced during human infection [56].
Although the TMDH screen is primarily intended to identify
attenuating mutants, it also may identify mutants that perform
better in vivo than in vitro, with attenuation scores significantly
greater than 0. The genes disrupted in these ‘‘hypercompetitive’’
mutants may impair the infection process in wild-type strains.
There are fewer examples of such mutants in our dataset than
attenuating mutants (see Figure 5) – intuitively it is easier to see
how the infection process may be disrupted than enhanced – and
many of the genes at this end of the list have poor P-values.
Nevertheless a few plausible candidate hypercompetitive mutants
are identified. These include several genes involved in flagellar
biosynthesis (flgCEFKI, flhB and fliFHIJKRT), mutants of which are
known to display enhanced virulence [57]; the global transcrip-
tional regulator gene fnr, mutants of which show enhanced entry
into and proliferation within HEp-2 epithelial cells [58]; dsdA,
which encodes a positive regulator of D-serine deaminase and
which when mutated enhances the ability of uropathogenic E. coli
to infect the bladder and kidneys of mice [59]; and araH, the loss of
which is associated with virulence in Burkholderia mallei [60]. There
are also several putative hypercompetitive mutants associated with
Type II secretion (hofQ, hofC, hopD and ppdA).
Validation of targets selected by TMDH
47 of the genes identified in the TMDH screen were subjected
to further investigation by generating defined deletion mutants and
performing single mutant infection assays. The set of 47 genes was
chosen to reflect a range of attenuation scores, and to include a
number of potential live vaccine candidates. It should be noted
that some mutants may be attenuated in parallel infection screens
such as TMDH due to their inability to compete with the other
mutants in the pool, but not show any evidence of attenuation
during a single mutant infection. The reverse is also possible, since
Figure 9. TMDH data obtained for SPI-1, 3, 4, 5, 6 and 9. Transposon inserts within all of these regions result in similar microarray signals in the
input and output datasets, suggesting that these regions are not important for infection in our model.
doi:10.1371/journal.ppat.1000529.g009
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a mutant may be able to overcome its deficiency in the presence of
other genotypes, for example through the uptake of a compound
secreted by the other bacteria. Also, within the TMDH screen,
different transposon mutants within the same gene are not
necessarily comparable. The transposon may be inserted in a
different position within the gene, or a mutant may perform
differently in the context of a different pool of mutants. Despite
these caveats, Figure 6 demonstrates a significant correlation
between the average attenuation score and the average log10
colony counts from day 3 of the single mutant infection
experiments. This indicates that TMDH attenuation scores
accurately reflect the levels of attenuation seen when defined
deletion mutants are generated and investigated individually.
TMDH therefore represents an effective screen for genes that are
important for infection.
Some of the attenuating mutants selected by TMDH were
investigated further for their ability to elicit an immune response
that would be protective against subsequent challenge with a wild
type strain. atpA and trxA defined deletion mutants protected
against wild-type challenge (Figure 7) and further details of similar
experiments for another promising candidate, tolA, have recently
been published [25]. This demonstrates the power of TMDH as a
screen for identifying mutants that act as novel live-attenuated
vaccine strains.
Supporting Information
Table S1 TMDH attenuation scores for 8533 transposon
mutants. Predicted transposon locations, attenuation scores and
P-values for 8533 transposon insertions identified using TMDH.
The list is ordered by attenuation score.
Found at: doi:10.1371/journal.ppat.1000529.s001 (10.39 MB
XLS)
Table S2 Transposon locations confirmed by sequencing.
Transposon insertion locations predicted by TMDH and con-
firmed by sequencing for 37 randomly chosen mutants from Set6,
and 13 mutants chosen from Set1 and Set3 based on the
microarray data.
Found at: doi:10.1371/journal.ppat.1000529.s002 (0.03 MB XLS)
Table S3 In vivo attenuation of defined deletion mutants. Mean
day 3 colony counts per liver for mice infected i.v. with wild type
SL1344 or defined deletion mutants. P-value indicates probability
that the mean day 3 count obtained for the mutant differs from
that of wild type SL1344, as determined using an unpaired
Student’s t-test.
Found at: doi:10.1371/journal.ppat.1000529.s003 (0.03 MB XLS)
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